Show items per page
Elements: 34
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard 2003
add to browser selection
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard 2003
add to browser selection
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; ... Perrin, Luc 2002
add to browser selection
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study Hasse, Barbara; Ledergerber, Bruno; Egger, Mathias; Egger, Martin; ... Gunthard, Huldrych 2004
add to browser selection
Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy Fischer, Marek; Joos, Beda; Wong, J. K.; Ott, Peter; ... Gunthard, Huldrych 2004
add to browser selection
Biphasic decline of CD4 cell count during scheduled treatment interruptions Fagard, Catherine; Bandelier, C. Y.; Ananworanich, Jintanat; Le Braz, Michelle; ... Hirschel, Bernard 2005
add to browser selection
Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef Fischer, Marek; Joos, Beda; Hirschel, Bernard; Bleiber, Gabriela; ... Gunthard, Huldrych 2004
add to browser selection
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load Oxenius, A.; Gunthard, Huldrych; Hirschel, Bernard; Fidler, S.; ... Price, D. A. 2001
add to browser selection
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure Rauch, Andri; James, Ian; Pfafferott, Katja; Nolan, David; ... Gaudieri, Silvana 2009
add to browser selection
Drug resistance mutations during structured treatment interruptions Yerly Ferrillo, Sabine; Fagard, Catherine; Gunthard, Huldrych; Hirschel, Bernard; Perrin, Luc 2003
add to browser selection
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression Frater, A. John; Brown, H.; Oxenius, A.; Gunthard, Huldrych; ... Phillips, R. E. 2007
add to browser selection
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; Burgisser, Philippe; ... Gunthard, Huldrych 2007
add to browser selection
Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions Metzner, K. J.; Bonhoeffer, Sebastian; Fischer, Marek; Karanicolas, Rose; ... Gunthard, Huldrych 2003
add to browser selection
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load Oxenius, Annetie; Sewell, A. K.; Dawson, S. J.; Gunthard, Huldrych; ... Price, D. A. 2002
add to browser selection
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Rauch, Andri; Kutalik, Zoltan; Descombes, Patrick; Cai, Tao; ... Bochud, Pierre-Yves 2010
add to browser selection
HIV rebounds from latently infected cells, rather than from continuing low-level replication Joos, Beda; Fischer, Marek; Kuster, Herbert; Pillai, S. K.; ... Gunthard, Huldrych 2008
add to browser selection
HIV RNA in plasma rebounds within days during structured treatment interruptions Fischer, Marek; Hafner, Roland; Schneider, Christine; Trkola, Alexandra; ... Gunthard, Huldrych 2003
add to browser selection
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss Schupbach, Jorg; Gunthard, Huldrych; Joos, Beda; Fischer, Marek; ... Hirschel, Bernard 2005
add to browser selection
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection Trkola, Alexandra; Kuster, Herbert; Leemann, Christine; Ruprecht, Claudia; ... Gunthard, Huldrych 2003
add to browser selection
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy Oxenius, Annette; McLean, A. R.; Fischer, Marek; Price, D. A.; ... Gunthard, Huldrych 2002
<< previous | 1 | 2 |